

Behind the Money
Financial Times
From hostile takeovers to C-suite intrigue, Behind the Money takes you inside the business and financial stories of the moment with reporting from Financial Times journalists around the world. Hosted on Acast. See acast.com/privacy for more information.
Episodes
Mentioned books

Oct 30, 2018 • 17min
How €200bn of ‘dirty money’ flowed through a Danish bank
How did Denmark’s Danske Bank find itself at the centre of one of the largest money laundering scandals the world has ever seen? The FT’s Richard Milne explains. Hosted on Acast. See acast.com/privacy for more information.

Oct 16, 2018 • 19min
The future of dealmaking with Saudi Arabia
Some of the world’s most influential financiers and executives have spent the past three years courting Saudi Arabia’s dealmaker-in-chief Mohammed bin Salman and his $300bn state investment fund. But the disappearance of Saudi journalist Jamal Khashoggi has turned the pursuit of trophy deals into an exercise in crisis management. The FT's Arash Massoudi explains how the crown prince sought to modernise the Saudi economy with support of the global business elite, and what the future holds for dealmaking with the kingdom.Review clips: CNBS, Bloomberg, Fox Business Network, France 24, WSJ.com. Hosted on Acast. See acast.com/privacy for more information.

Oct 10, 2018 • 22min
The rise and fall of General Electric
In this insightful discussion, Ed Crooks, the US industry and energy editor for the Financial Times, explores the dramatic rise and fall of General Electric. He delves into GE's historic growth to a $600 billion valuation and the pivotal challenges it faced with its Alstom acquisition. Crooks highlights critical miscalculations in the shift towards renewable energy and how leadership changes impacted GE's financial strategies. Finally, he discusses the company's future as it pivots away from conglomeratization, emphasizing the lessons learned from past failures.

Oct 8, 2018 • 31sec
Tune in Wednesday
This week's episode of Behind The Money will be available on Wednesday morning, instead of our usual time on Tuesday. Be sure to check back Wednesday morning for a brand episode. Hosted on Acast. See acast.com/privacy for more information.

Oct 2, 2018 • 20min
Private equity's debt mountain (encore episode)
Private equity has flooded the deal market in recent years, in part due to an era of cheap debt and fund managers on the hunt for greater investment returns. Firms are scooping up stakes in oil pipelines and newspapers — and even dental clinics. With a record $1.8tn in pension and sovereign wealth fund money waiting to be invested, some analysts are asking when private equity’s winning run will come to an end. With the FT's Javier Espinoza. Read more here. Review clips: CNBC, NBC, Bloomberg. Hosted on Acast. See acast.com/privacy for more information.

Sep 25, 2018 • 17min
Tilray and the cannabis trade
The Canadian company was the first cannabis producer to make an initial public offering on a US stock exchange, and, after a week of volatile trading, some analysts are asking if investor excitement has gotten ahead of reality. The FT's Nicole Bullock explains.Review clips: Fox Business Network, ABC, CBS, BNN Bloomberg, CNBC, Bloomberg. Music by Podington Bear. Hosted on Acast. See acast.com/privacy for more information.

Sep 18, 2018 • 24min
On the front lines of the crisis
Nick was a regulator at the London Stock Exchange. Julia was an entrepreneur whose home was foreclosed. Ten years on from the collapse of Lehman Brothers we talk to two people with different perspectives on the lessons of the global financial crisis.Review clips: AP, CBS. Hosted on Acast. See acast.com/privacy for more information.

Sep 11, 2018 • 21min
Purdue Pharma's 'one-two' punch
The name “Sackler” adorns museums and art galleries around the world. But the family name has also become tainted by its association with the US opioid crisis, amid accusations that OxyContin, more than any other drug, is responsible for sparking one of the worst public health epidemics of modern times. The FT's David Crow explains how the Sackler family company Purdue Pharma got its hold on the opioid market. Hosted on Acast. See acast.com/privacy for more information.

Sep 4, 2018 • 20min
Following the cannabis money trail (encore episode)
Medical marijuana is legal in 21 countries. In Canada, residents expect they will be able to buy cannabis from dispensaries and pharmacies across the country later this year. Some analysts have valued the legal business at anywhere between $7bn-$20bn, attracting a host of entrepreneurs and investors trying to get in on the action before the market takes off. We talk to two entrepreneurs with two very different plans to capitalise on the boom. This episode was originally published on June 12, 2018. Read more about the cannabis sector on FT.com. Hosted on Acast. See acast.com/privacy for more information.

Aug 28, 2018 • 20min
Khosrowshahi's year at the wheel
A little more than a year ago, Uber's board was in search of a new chief executive. Co-founder Travis Kalanick had resigned from the top job amid allegations of a toxic and sexist company culture, and the board was looking for someone to fix the group's operations and ready it for what is expected to be the tech world's biggest public offering. Behind The Money looks at Dara Khosrowshahi's first year at the helm. With the FT's Shannon Bond. Review clips: ABC News, WSJ, NBC News, CBS News, CNBC, Fox Business Network Hosted on Acast. See acast.com/privacy for more information.